# Cadiz Inc: overview CDZI · Nasdaq · CIK 727273 · [Utilities](/sectors/utilities.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/cdzi.md) · [Financials](/companies/cdzi/financials.md) · [Filings](/companies/cdzi/filings.md) · [Insiders](/companies/cdzi/insiders.md) Latest reported revenue: [$979.0k](/filings/0001437749-26-027664.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 13, 2026 (XBRL us-gaap:Revenues, accession 0001437749-26-027664). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [3,224](/filings/0001437749-25-034647.md) | [4,750 d](/filings/0001437749-26-010517.md) | [2,954](/filings/0001437749-26-017051.md) | [4,126](/filings/0001437749-26-027664.md) | [4,149](/filings/0001437749-25-034647.md) | [5,084 d](/filings/0001437749-26-010517.md) | [1,632](/filings/0001437749-26-017051.md) | [979](/filings/0001437749-26-027664.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(147.9%)](/filings/0001437749-25-034647.md) | [(139.5%) d](/filings/0001437749-26-010517.md) | [(255.0%)](/filings/0001437749-26-017051.md) | [(140.0%)](/filings/0001437749-26-027664.md) | [(118.0%)](/filings/0001437749-25-034647.md) | [(145.4%) d](/filings/0001437749-26-010517.md) | [(418.8%)](/filings/0001437749-26-017051.md) | [(902.5%)](/filings/0001437749-26-027664.md) | | Net margin | % | [(210.7%)](/filings/0001437749-25-034647.md) | [(181.6%) d](/filings/0001437749-26-010517.md) | [(324.7%)](/filings/0001437749-26-027664.md) | [(187.3%)](/filings/0001437749-26-027664.md) | [(170.5%)](/filings/0001437749-25-034647.md) | [(191.9%) d](/filings/0001437749-26-010517.md) | [(529.2%)](/filings/0001437749-26-027664.md) | [(1161.8%)](/filings/0001437749-26-027664.md) | | Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Free cash flow | $k | [(5,441) d](/filings/0001437749-25-034647.md) | [(6,622) d](/filings/0001437749-26-010517.md) | [(4,933)](/filings/0001437749-26-017051.md) | [(5,867) d](/filings/0001437749-26-027664.md) | [(7,460) d](/filings/0001437749-25-034647.md) | [(8,246) d](/filings/0001437749-26-010517.md) | [(5,752)](/filings/0001437749-26-017051.md) | [(9,768) d](/filings/0001437749-26-027664.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL not reported. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [0.6](/filings/0001437749-23-008639.md) | [1.5](/filings/0001437749-24-009847.md) | [2.0](/filings/0001437749-25-009714.md) | [9.6](/filings/0001437749-26-010517.md) | [16.3](/filings/0001437749-26-010517.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(3105.0%)](/filings/0001437749-23-008639.md) | [(1103.4%)](/filings/0001437749-24-009847.md) | [(1051.7%)](/filings/0001437749-25-009714.md) | [(242.0%)](/filings/0001437749-26-010517.md) | [(156.9%)](/filings/0001437749-26-010517.md) | | Net margin | % | [(5540.6%)](/filings/0001437749-23-008639.md) | [(1651.7%)](/filings/0001437749-24-009847.md) | [(1579.4%)](/filings/0001437749-25-009714.md) | [(324.1%)](/filings/0001437749-26-010517.md) | [(209.3%)](/filings/0001437749-26-010517.md) | | Diluted EPS | $ per share | [(0.84)](/filings/0001437749-22-007512.md) | not reported | not reported | not reported | not reported | | Free cash flow | $m | [(38.2)](/filings/0001437749-23-008639.md) | [(22.0)](/filings/0001437749-24-009847.md) | [(26.7)](/filings/0001437749-25-009714.md) | [(22.5)](/filings/0001437749-26-010517.md) | [(26.5)](/filings/0001437749-26-010517.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareBasicAndDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/cdzi/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $21.5m | 5,135,402 | | Added +1,307,115 | | [LEVIN CAPITAL STRATEGIES, L.P.](/funds/1354821.md) | 2026-06-30 | $18.8m | 4,496,579 | | Added +680,410 | | [Whitefort Capital Management, LP](/funds/1884931.md) | 2026-06-30 | $16.7m | 3,986,822 | | Unchanged | | [BANK OF AMERICA CORP /DE/](/funds/70858.md) | 2026-06-30 | $14.7m | 3,518,928 | | Reduced −9,366 | | [BARCLAYS PLC](/funds/312069.md) | 2026-06-30 | $14.5m | 3,469,347 | | Reduced −251,838 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $10.3m | 2,473,582 | | Added +117,269 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $6.2m | 1,481,764 | | Added +89,642 | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $5.9m | 1,407,369 | | Added +72,249 | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $4.2m | 1,005,149 | | Reduced −32,320 | | [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $3.2m | 765,170 | | Added +434,899 | ## Recent filings [All 851 filings](/companies/cdzi/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-29 | 16:20 ET | [8-K](/filings/0001213900-26-113824.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-113824 | | 2026-10-29 | 08:42 ET | [10-K/A](/filings/0001213900-26-113579.md) | Annual report, amended, period 2025-12-31 | 0001213900-26-113579 | | 2026-08-13 | 16:06 ET | [10-Q](/filings/0001437749-26-027664.md) | Quarterly report, period 2026-06-30 | 0001437749-26-027664 | | 2026-07-28 | 16:41 ET | [8-K](/filings/0001213900-26-082311.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-082311 | | 2026-07-27 | 08:00 ET | [8-K](/filings/0001213900-26-081581.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-081581 | | 2026-07-15 | 09:00 ET | [8-K](/filings/0001213900-26-078146.md) | 8.01 Other events | 0001213900-26-078146 | | 2026-06-23 | 15:42 ET | [8-K](/filings/0001437749-26-021420.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-26-021420 | | 2026-05-20 | 16:20 ET | [8-K](/filings/0001437749-26-017950.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-017950 | | 2026-05-14 | 16:10 ET | [10-Q](/filings/0001437749-26-017051.md) | Quarterly report, period 2026-03-31 | 0001437749-26-017051 | | 2026-04-30 | 11:00 ET | [DEF 14A](/filings/0001437749-26-014053.md) | Proxy statement, period 2026-06-18 | 0001437749-26-014053 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001437749-26-010517.md), filed Mar 31, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/648ab74c-3683-4b88-9790-64fd69d6885c) ## About the filer - CIK: 727273 - Tickers: CDZI, CDZIP - Exchange: Nasdaq - SIC code: 4941 Water Supply - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 16:21 ET. No prices; not investment advice.